Update on the EU MDR delay and impact on industry - Panel discussion

With confirmation of the EU MDR delay due to COVID-19, MedTech Summit brought together four industry insiders to discuss the update and the impacts it will have on industry. The video discussion features:

• Gert Bos, Executive Director & Partner at Qserve Group, The Netherlands
• Annabelle Bruydonckx, Counsel at Simmons & Simmons LLP, Belgium
• James Whitehead, Patient Safety Medical Device Lead at AstraZeneca, UK
• Vladimir Murovec, Supervising Associate (Healthcare & Life Sciences) at Simmons & Simmons, Belgium

Rebecca Brady, Senior Conference Producer at Informa Life Sciences, led the discussion, which you can watch in full below (or here):